| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6193775 | Practical Radiation Oncology | 2011 | 6 Pages |
Abstract
Patients with LC have aggressive disease with few long-term survivors. Definitive treatment with TSEB should be utilized only in cases of marrow remission with focal electron therapy reserved for palliation of symptomatic lesions. Long-term prognosis and durable cutaneous remission is dependent on systemic disease control.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Richard MD, Joachim MD,